INmune Bio saw its stock surge 75% in after-hours trading Thursday after disclosing plans to unveil topline results from its Phase 2 Alzheimer’s trial on Monday. The company will present findings from ...

This was the stock's second consecutive day of losses.

Upstream Bio to present novel data on verekitug's potency at EAACI Congress 2025, targeting respiratory inflammatory diseases.

A memo that purports to summarize a meeting held by members of a biotech trade group suggests deep concern about RFK Jr.’s ...

Participants in trials of BrainStorm Cell Therapeutics' NurOwn filed a Citizens’ Petition with the FDA earlier this month ...

At BIO 2025 in Boston today, pharma and biotech leaders discussed the current state of AI in the drug development life cycle.

Brii Bio Presents Late-Breaking Data from Its Ongoing Phase 2 ENSURE Study at EASL Congress 2025, Suggesting BRII-179's Role in Advancing Higher HBsAg Loss Brii Bio Presents Late-Breaking Data ...

Looking for a biopharma job in Illinois? Check out the BioSpace list of six companies hiring life sciences professionals like you.

The U.S. FDA is insisting that another study is needed to bolster the sNDA for Rexulti (brexpiprazole) from Otsuka Pharmaceutical Co. Ltd. in treating adults with post-traumatic stress disorder (PTSD) ...

Adaptive Computation LLC Assessed “Awardable” for DARPA[JR1] ERIS Marketplace – Adaptive Computation LLC, a leading provider ...

Gossamer Bio's seralutinib shows promise in PAH Phase 2 trials, but Phase 3 success is vital amidst competition. Click to read more on the risks and Hold rating insights.